Safety and Efficacy of the Full Face Applications of Variable Doses of a Commercial Botulinum Toxin Type a (Dysport®)
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label and phase IV study of full face injections of variable doses of
botulinum toxin type A (BT-A). As it is an open-label and not blind study, both investigator
and subjects will know the injection local and doses of the study drug. Patients will be
randomized into 3 different groups. Each group will receive a specific dose according with
the indication evaluated by the investigator. Six visits will be schedule in this study.
Phase:
Phase 4
Details
Lead Sponsor:
Brazilan Center for Studies in Dermatology
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA